• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchPolyrizon
    Picture of Polyrizon logo

    PLRZ — Polyrizon News Story

    $8.730.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    • Market Cap
      $20.70m
    • Enterprise Value
      $4.62m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • PLRZ Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    PLRZ Dividends
    All News

    NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:04 AM

    Picture of Polyrizon logoPolyrizon
    02/12/2025 15:04
    NASDAQ TRADE HALT  PLRZ.O  VOLATILITY TRADING PAUSE AT 10:04 AM
    

    Recent news on Polyrizon

    See all news
    • Brief: Polyrizon Files For U.S. Patent Application To Expand Ip Moat Around Intranasal Drug-Delivery Platform

      05/10/2026 12:39
    • Brief: Polyrizon Advances Towards Human Clinical Trials Secures First U.S. Clinical Site For Nasarix™ Allergy Blocker Clinical Trial

      13/05/2026 14:29
    • NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:58 AM

      28/04/2026 14:58
    • Enters Agreements For Registered Direct Offering Of Ordinary Shares And Pre-Funded Warrants

      07/04/2026 13:05
    • U.S. STOCKS ON THE MOVE-Enovis, Cheniere, Packaging Corp of America

      26/02/2026 18:45

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.